Treace Medical Concepts Reports Fourth Quarter and Full Year 2021 Financial Results
March 03, 2022 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., March 03, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a paradigm shift in the...
Treace Announces Updated ALIGN3D™ Data at the 2022 ACFAS Scientific Conference
February 25, 2022 12:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 25, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...
Treace Highlights New Product Innovations at the 2022 ACFAS Scientific Conference
February 23, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...
Treace to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
February 14, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...
Treace to Announce Latest ALIGN3D™ Data at the 2022 ACFAS Scientific Conference
February 01, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...
Treace Announces Grant of U.S. Patent on Instrumented Bunion Correction
January 19, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a...
Treace Medical Concepts Provides 2021 Preliminary Sales Results
January 10, 2022 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a...
Treace to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022
January 07, 2022 08:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...
Treace Announces Grant of U.S. Patent and Allowance of U.S. Patent Application on Bone Positioner Technology for Bunion Correction
November 30, 2021 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a...
Treace Announces Participation in the Stifel 2021 Virtual Healthcare Conference
November 09, 2021 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the...